from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3625c/mesJ

LFCtreatmentdescriptionclass of inhibitor

-0.620

Amikacinug/mL Amikacintranslation

-1.315

Cap5-10ug/mL Capreomycintranslation

-1.287

Rox10-50 ug/mL Roxithromycintranslation

-0.559

SM2-5 ug/mL Streptomycintranslation

-0.994

Tet5-10 ug/mL Tetracyclinetranslation

0.943

Rif0.2-5ug/mL Rifampicintranscription

0.716

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.372

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.130

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.666

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-4.870

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.402

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.038

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.611

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.842

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.498

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.458

Nigericin50 uM Nigericinrespiration

0.452

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.329

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.439

menadione6-10 ug/mL Menadionerespiration

0.021

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.716

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.350

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.671

NRP_1Non-replicating persistence stage 1dosRassociated

-0.424

Amp0.2mg/mL AmpicillincellWall

-0.182

Cephalexin20-100 ug/mL CephalexincellWall

-0.542

Cerulenin0.32-5 ug/mL CerulenincellWall

0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.147

EMB10-20 ug/mL EthambutolcellWall

-0.816

Eta12-40 ug/mL EthionamidecellWall

-0.457

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.187

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.014

BZA0.12 mg/mL BenzamidearomaticAmides

0.132

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.194

H2O24 mM hydrogen peroxideDNAdamaging

-0.286

Levo10 ug/mL LevofloxacinDNAdamaging

0.050

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.660

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.455

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.020

Antimycin12.5-50 ug/mL Antimycin A?

-2.945

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.013

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.251

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.828

PA8240.2-2 ug/mL PA-824?

0.626

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.820

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.052

Verapamil50 uM Verapamil?

1.136

mercaptoethanol2 mM 2-Mercaptoethanol?

1.225

methoxatin10-20 ug/mL Methoxatin?